Skip to Content

TAK ALG-25 (Nesina 25 mg)

Generic Name: alogliptin

Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-25

Nesina 25 mg TAK ALG-25

Nesina

Generic Name:
alogliptin
Imprint:
TAK ALG-25
Strength:
25 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0250

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide